Ashish Bajel Selected Research

Ashish Bajel Research Topics

Disease

7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 03/2012
7	Infections 11/2021 - 05/2010
5	COVID-19 07/2022 - 01/2020
3	Leukemia 06/2021 - 12/2010
3	Neoplasms (Cancer) 04/2021 - 12/2016
3	Primary Myelofibrosis (Myelosclerosis) 04/2021 - 01/2017
3	Mycoses (Diseases, Fungus) 07/2013 - 03/2012
2	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2022 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 11/2008
2	Multiple Myeloma 01/2020 - 08/2013
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2018 - 03/2012
1	Fever (Fevers) 08/2022
1	Virus Diseases (Viral Diseases) 11/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Disease Progression 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Pathologic Complete Response 01/2020
1	Mucositis 01/2020
1	Sepsis (Septicemia) 10/2019
1	Body Weight (Weight, Body) 12/2018
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2017
1	Splenomegaly 03/2017
1	Nausea 01/2017
1	Polycythemia Vera 01/2017
1	Headache (Headaches) 01/2017
1	Essential Thrombocythemia 01/2017
1	Fatigue 01/2017
1	Dyspnea (Shortness of Breath) 01/2017
1	Sleepiness 01/2017
1	Dizziness (Lightheadedness) 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2016
1	Lymphoma (Lymphomas) 08/2013
1	Central Nervous System Diseases (CNS Diseases) 08/2013
1	Aspergillosis 06/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2012
1	Invasive Fungal Infections 05/2010
1	Iron Deficiencies 12/2008
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 12/2008
1	Iron Overload 12/2008
1	Hemochromatosis (Bronze Diabetes) 12/2008
1	Acute Promyelocytic Leukemia 04/2006

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 04/2022 - 03/2017
3	posaconazole FDA Link 12/2016 - 05/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2022 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 06/2022 - 08/2013
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 06/2013
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2008
2	venetoclaxIBA 01/2021 - 01/2021
2	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 07/2012
2	Busulfan (Busulfex)FDA Link 01/2020 - 07/2012
2	Voriconazole (Vfend)FDA LinkGeneric 03/2012 - 05/2010
1	Cytotoxins (Cytolysins)IBA 04/2022
1	Pyridinolcarbamate (P23)IBA 04/2021
1	navitoclaxIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	TeicoplaninIBA 03/2020
1	Vancomycin FDA LinkGeneric 03/2020
1	fludarabineIBA 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020
1	Calcineurin InhibitorsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	ruxolitinibIBA 03/2017
1	Janus Kinase 1IBA 03/2017
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 01/2017
1	Rituximab (Mabthera)FDA Link 08/2013
1	Antifungal AgentsIBA 07/2013
1	galactomannanIBA 06/2013
1	Fibroblast Growth Factor 7 FDA Link 07/2012
1	Fluconazole (Zonal)FDA LinkGeneric 03/2012
1	SolutionsIBA 03/2012
1	Itraconazole (Sporanox)FDA LinkGeneric 03/2012
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 12/2010
1	Hemoglobins (Hemoglobin)IBA 12/2008
1	ElementsIBA 12/2008
1	IronIBA 12/2008
1	Arsenic Trioxide (Trisenox)FDA Link 04/2006

Therapy/Procedure

9	Therapeutics 07/2022 - 08/2013
8	Drug Therapy (Chemotherapy) 08/2022 - 03/2012
5	Transplantation 12/2021 - 05/2017
4	Cell Transplantation 06/2022 - 01/2017
3	Stem Cell Transplantation 08/2022 - 06/2013
2	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2020
1	Drug Tapering 06/2022
1	Critical Care (Surgical Intensive Care) 11/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021
1	Immunotherapy 01/2020
1	Homologous Transplantation 01/2020
1	Catheters 10/2019
1	Remission Induction 03/2012
1	Oral Administration 05/2010
1	PVDA protocol 11/2008